Cite
HARVARD Citation
Miyamoto, S. et al. (n.d.). 1425PABCB1 genetic polymorphism and pharmacokinetic analysis of low dose erlotinib in frail patients with EGFR mutation (mt)-positive, non-small cell lung cancer: TORG1425. Annals of oncology. p. . [Online].